Drug
Dantrolene clinical trials
Also written Dantrium.
- studies test it
- 10
- open now
- 2
- in phase 3
- 3
- first study started
- 2007
Keep track of what changes. Save the Dantrolene studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2017 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 10
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 9
University of Massachusetts, Worcester (2) · Vanderbilt University Medical Center (1) · Beth Israel Deaconess Medical Center (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Washington University School of Medicine (1) · Eagle Pharmaceuticals, Inc. (1) · Tanta University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Often tested with
Tested in the same studies.
Propranolol (1) · Pindolol (1) · Magnesium Sulfate (1) · Caffeine (1) · Qsymia (1) · Topiramate (1) · Naltrexone (1) · Mirabegron (1)
Studies
Open first, then newest update. How each study uses Dantrolene is read from its arms, and is right about nine times in ten.
Testing it · 10
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)RecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT03109288Written as Dantrolene
- Dantrolene in Statin-induced MyopathyNot yet recruitingPhase 2/3Tanta UniversityNCT06966843Written as Dantrolene
- A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.CompletedPhase 2/3Vanderbilt University Medical CenterNCT04134845Written as Dantrolene/Ryanodex
- The Use of Dantrolene to Improve Analgesia in Posterior Lumbar SurgeryCompletedPhase 2Beth Israel Deaconess Medical CenterNCT03762109Written as Dantrolene
- Study of Human Non-Shivering Thermogenesis and Basal Metabolic RateCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT01950520Written as Dantrolene
- A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram SyndromeCompletedPhase 1/2Washington University School of MedicineNCT02829268Written as dantrolene sodium
- Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)CompletedPhase 2Eagle Pharmaceuticals, Inc.NCT02513095Written as Dantrolene sodium for injectable suspension
- Safety Study of Dantrolene in Subarachnoid HemorrhageCompletedPhase 1/2University of Massachusetts, WorcesterNCT01024972Written as Dantrolene
- Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid HemorrhageCompletedPhase 1/2University of Massachusetts, WorcesterNCT00964548Written as Dantrolene
- Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)TerminatedPhase 2/3Medical University of ViennaNCT00796900Written as Dantrolene
As the comparator · 1 — what is tested is compared with Dantrolene
Codes
What other systems call Dantrolene · ClinicalTrials.gg INT007298
- MeSH (NLM) D003620DantroleneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) F64QU97QCRDANTROLENEConfirmed FDA, NLM, Wikidata
- RxNorm 3105Confirmed FDA, Wikidata
- Wikidata Q421274dantroleneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61697DantroleneOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003620 | Dantrolene | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | F64QU97QCR | DANTROLENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 3105 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421274 | dantrolene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61697 | Dantrolene | One source FDA |
Also registered as dantrolene sodium (UNII 287M0347EV · RxNorm 3106).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.